Gene Therapy Trials in Hemophilia A and B

作者: Katherine A High , None

DOI: 10.1002/9781118398258.CH41

关键词:

摘要:

参考文章(97)
Gilbert C White II, None, Gene therapy in hemophilia: clinical trials update. Thrombosis and Haemostasis. ,vol. 86, pp. 172- 177 ,(2001) , 10.1055/S-0037-1616215
S Connelly, JM Gardner, RM Lyons, A McClelland, M Kaleko, Sustained expression of therapeutic levels of human factor VIII in mice Blood. ,vol. 87, pp. 4671- 4677 ,(1996) , 10.1182/BLOOD.V87.11.4671.BLOODJOURNAL87114671
Roland W. Herzog, Edmund Y. Yang, Linda B. Couto, J. Nathan Hagstrom, Dan Elwell, Paul A. Fields, Melissa Burton, Dwight A. Bellinger, Marjorie S. Read, Kenneth M. Brinkhous, Gregory M. Podsakoff, Timothy C. Nichols, Gary J. Kurtzman, Katherine A. High, LONG-TERM CORRECTION OF CANINE HEMOPHILIA B BY GENE TRANSFER OF BLOOD COAGULATION FACTOR IX MEDIATED BY ADENO-ASSOCIATED VIRAL VECTOR Nature Medicine. ,vol. 5, pp. 56- 63 ,(1999) , 10.1038/4743
I. E. M. Den UIJL, E. P. MAUSER BUNSCHOTEN, G. ROOSENDAAL, R. E. G. SCHUTGENS, D. H. BIESMA, D. E. GROBBEE, K. FISCHER, Clinical severity of haemophilia A: does the classification of the 1950s still stand? Haemophilia. ,vol. 17, pp. 849- 853 ,(2011) , 10.1111/J.1365-2516.2011.02539.X
Xiaolin Wu, Yuan Li, Bruce Crise, Shawn M Burgess, Transcription start regions in the human genome are favored targets for MLV integration. Science. ,vol. 300, pp. 1749- 1751 ,(2003) , 10.1126/SCIENCE.1083413
Virginie Monteilhet, Samir Saheb, Sylvie Boutin, Christian Leborgne, Philippe Veron, Marie-Françoise Montus, Philippe Moullier, Olivier Benveniste, Carole Masurier, A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8 Molecular Therapy. ,vol. 19, pp. 2084- 2091 ,(2011) , 10.1038/MT.2011.108
Lili Wang, Joanita Figueredo, Roberto Calcedo, Jianping Lin, James M. Wilson, Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets. Human Gene Therapy. ,vol. 18, pp. 185- 194 ,(2007) , 10.1089/HUM.2007.001
Roland W. Herzog, Paul A. Fields, Valder R. Arruda, Jeff O. Brubaker, Elina Armstrong, Darryl McClintock, Dwight A. Bellinger, Linda B. Couto, Timothy C. Nichols, Katherine A. High, Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy Human Gene Therapy. ,vol. 13, pp. 1281- 1291 ,(2002) , 10.1089/104303402760128513
Mark A. Kay, Catherine S. Manno, Margaret V. Ragni, Peter J. Larson, Linda B. Couto, Alan McClelland, Bertil Glader, Amy J. Chew, Shing J Tai, Roland W. Herzog, Valder Arruda, Fred Johnson, Ciaran Scallan, Erik Skarsgard, Alan W. Flake, Katherine A. High, Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector Nature Genetics. ,vol. 24, pp. 257- 261 ,(2000) , 10.1038/73464